Responses
Scientific Abstracts
Rheumatoid arthritis - other biologictreatment
SAT0137 Early Clinical Improvements (Week 4) Predict Subsequent Clinical Response with Ixekizumab in Rheumatoid Arthritis Patients with Inadequate Response to tnf Inhibitors
Compose a Response to This Article
Other responses
No responses have been published for this article.